encainide
Sign in to saveAlso known as (+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide, 4-Methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide, 4-Methoxy-N-{2-[2-(1-methyl-piperidin-2-yl)-ethyl]-phenyl}-benzamide, (+-)-2'-[2-(1-Methyl-2-piperidyl)ethyl]-P-anisanilide, Encainida, Encainidum, (±)-4-methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)benzamide
Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because of its frequent proarrhythmic side effects.
Research
454 papers- Encainide.Cardiovascular drugs and therapy · 1989
- Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.The New England journal of medicine · 1991
- Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.The New England journal of medicine · 1989
- [Encainide].Medicina (Florence, Italy) · 1988
- Encainide--an updated safety profile.Cardiovascular drugs and therapy · 1990
via PubMed
~1 min read
Encyclopedic overview
3 sectionsContents
- Synthesis
- See also
- References
Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because of its frequent proarrhythmic side effects.
==Synthesis== thumb|500px|center|Synthesis:<
Excerpted from Wikipedia’s “encainide” article, available under the CC BY-SA 4.0 licence.
Available in 8 languages
via Wikidata sitelinks · CC0